Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Breast Neoplasms, Male (Phase 1/Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Glioblastoma (Phase 2)
Gliosarcoma (Phase 2)
Granuloma (Phase 2)
Hypopharyngeal Neoplasms (Phase 2)
Laryngeal Neoplasms (Phase 2)
Mouth Neoplasms (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 2)
Oropharyngeal Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Papilloma, Inverted (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Tongue Neoplasms (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue